Salience Clinical White Paper Series
Psilocybin at a Regulatory Crossroads: Five Unresolved Questions Shaping the Future of Psychedelic Medicine
Denis Katz, M.D. Founder & Medical Director, Salience Clinical LLC
Introduction
The optimism surrounding psilocybin is not unfounded. Early clinical findings have been striking enough to attract serious scientific attention, substantial investment, and a level of public interest that...
English
Arabic
Français
Español
Português
Türkçe
Dutch
Italiano
Russian
Romaian